Individual skill
dual-disease-shared-transcriptome-biomarker-research-planner
Generates complete dual-disease shared-transcriptome biomarker and hub-gene research designs from a user-provided disease pair and shared-biology direction. Always use this skill whenever a user wants to design, plan, or build a non-oncology two-disease transcriptome study centered on per-disease differential expression, shared-signal intersection or concordance, PPI-based hub-gene prioritization, diagnostic evaluation across both diseases, immune infiltration context, pathway interpretation, and optional orthogonal validation. Covers five study patterns (shared-DEG-first workflow, hub-gene-first shared-biomarker workflow, hybrid shared-biomarker compression workflow, immune-context shared-biomarker workflow, orthogonal validation workflow) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path...
awesome-med-research-skills/Protocol Design/dual-disease-shared-transcriptome-biomarker-research-planner/SKILL.md
Source commit 686e09dfdb45d9fa1a08664f06bb93769b3c9d91
What was checked
- Matches the observed repository HEAD
- Yes
- Scanner rules are current
- No
- Repository scan complete
- No
- Skill scan complete
- Yes
- Observed behavior
- Not checked yet
- Last checked
- Nov 9, 2026
These are observations at the recorded commit, not a guarantee of safety. Review the source before running it.
Install this skill
Choose an agent in your Stack or copy a command below. Commands fetch the pinned commit and copy only this skill directory. Existing destinations are refused. Copying a command does not install anything.
An install command is unavailable: current rules, complete repository and skill scans, an eligible behavior level and a permitted license are required.
Repository context
- Repository stars (not skill ratings)
- 2,043
- Repository last updated
- Sep 17, 2026
- License
- MIT
Observed agent integration: No specific integration evidence. Standard SKILL.md installation does not imply verified compatibility.
- bioinformatics Repository topic
- computational-biology Repository topic
- data-analysis Repository topic
- ai Repository topic
- biology Repository topic
- cancer-genomics Repository topic
- data-visualization Repository topic
- differential-expression Repository topic
- genomics Repository topic
- medical Repository topic
- research Derived category
Files and excerpt
File metadata and permitted, redacted excerpts come from the recorded scan. Source links are pinned to that commit.
Browse files
SKILL.mdcore · 17,131 byteseval_report_dual-disease-shared-transcriptome-biomarker-research-planner_result.jsonasset · 13,508 bytesreferences/analysis-modules.mddoc · 3,669 bytesreferences/figure-deliverable-plan.mddoc · 4,201 bytesreferences/literature-retrieval-and-citation.mddoc · 3,426 bytesreferences/method-library.mddoc · 2,777 bytesreferences/study-patterns.mddoc · 2,624 bytesreferences/validation-evidence-hierarchy.mddoc · 2,166 bytesreferences/workflow-step-template.mddoc · 3,742 bytesreferences/workload-configurations.mddoc · 6,616 bytes
Read excerpt
> **Source**: [https://github.com/aipoch/medical-research-skills](https://github.com/aipoch/medical-research-skills)
# Dual-Disease Shared-Transcriptome Biomarker Research Planner
You are an expert dual-disease bulk-transcriptome biomedical research planner.
**Task:** Generate a **complete, structured research design** — not a literature summary,
not a tool list. A real, executable study plan with four workload options and a recommended
primary path.
This skill is for conventional dual-disease shared-biomarker papers built around bulk expression datasets and clinically interpretable or biologically coherent shared endpoints. Typical article logic includes: disease A vs control differential expression, disease B vs control differential expression, shared-signal intersection or justified concordance integration, PPI-based hub-gene prioritization, diagnostic assessment in each disease, shared clinical or biological interpretation, immune infiltration context, single-gene pathway follow-up, and optional independent validation in both disease contexts.
---
## Input Validation